Abstract
Cardiac hypertrophy is an adaptive response to a variety of mechanical and hormonal stimuli, and represents an early event in the clinical course leading to heart failure. By gene inactivation, we demonstrate here a crucial role of melusin, a muscle-specific protein that interacts with the integrin β1 cytoplasmic domain, in the hypertrophic response to mechanical overload. Melusin-null mice showed normal cardiac structure and function in physiological conditions, but when subjected to pressure overload—a condition that induces a hypertrophic response in wild-type controls—they developed an abnormal cardiac remodeling that evolved into dilated cardiomyopathy and contractile dysfunction. In contrast, the hypertrophic response was identical in wild-type and melusin-null mice after chronic administration of angiotensin II or phenylephrine at doses that do not increase blood pressure—that is, in the absence of cardiac biomechanical stress. Analysis of intracellular signaling events induced by pressure overload indicated that phosphorylation of glycogen synthase kinase-3β (GSK-3β) was specifically blunted in melusin-null hearts. Thus, melusin prevents cardiac dilation during chronic pressure overload by specifically sensing mechanical stress.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chien, K.R. Stress pathways and heart failure. Cell 98, 555–558 (1999).
Chien, K.R. & Olson, E.N. Converging pathways and principles in heart development and disease: CV@CSH. Cell 110, 153–162 (2002).
Sadoshima, J. & Izumo, S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol. 59, 551–571 (1997).
Ruwhof, C. & van der Laarse, A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc. Res. 47, 23–37 (2000).
Sadoshima, J. & Izumo, S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 12, 1681–1692 (1993).
Schultz Jel, J. et al. TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J. Clin. Invest. 109, 787–796 (2002).
MacLellan, W.R. & Schneider, M.D. Genetic dissection of cardiac growth control pathways. Annu. Rev. Physiol. 62, 289–319 (2000).
Yamazaki, T. et al. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J. Biol. Chem. 271, 3221–3228 (1996).
Wettschureck, N. et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes. Nat. Med. 7, 1236–1240 (2001).
Akhter, S.A. et al. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280, 574–577 (1998).
Dorn, G.W. 2nd & Brown, J.H. Gq signaling in cardiac adaptation and maladaptation. Trends Cardiovasc. Med. 9, 26–34 (1999).
Wakasaki, H. et al. Targeted overexpression of protein kinase C β2 isoform in myocardium causes cardiomyopathy. Proc. Natl. Acad. Sci. USA 94, 9320–9325 (1997).
Sugden, P.H. & Clerk, A. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76, 725–746 (1998).
Hunter, J.J. & Chien, K.R. Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 341, 1276–1283 (1999).
Harada, K. et al. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation 97, 1952–1959 (1998).
Vecchione, C. et al. Cardiovascular influences of α1b-adrenergic receptor defect in mice. Circulation 105, 1700–1707 (2002).
Schwartz, M.A., Schaller, M.D. & Ginsberg, M.H. Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 11, 549–599 (1995).
Fassler, R. et al. Differentiation and integrity of cardiac muscle cells are impaired in the absence of β1 integrin. J. Cell Sci. 109, 2989–2899 (1996).
Keller, R.S. et al. Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis, and abnormal cardiac performance. Am. J. Pathol. 158, 1079–1090 (2001).
Shai, S.Y. et al. Cardiac myocyte-specific excision of the β1 integrin gene results in myocardial fibrosis and cardiac failure. Circ. Res. 90, 458–464 (2002).
Brancaccio, M. et al. Melusin is a new muscle-specific interactor for β1 integrin cytoplasmic domain. J. Biol. Chem. 274, 29282–29288 (1999).
Hirota, H. et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97, 189–198 (1999).
Badorff, C. et al. Fas receptor signaling inhibits glycogen synthase kinase 3β and induces cardiac hypertrophy following pressure overload. J. Clin. Invest. 109, 373–381 (2002).
Rockman, H.A., Koch, W.J. & Lefkowitz, R.J. Seven-transmembrane-spanning receptors and heart function. Nature 415, 206–212 (2002).
Haq, S. et al. Glycogen synthase kinase-3β is a negative regulator of cardiomyocyte hypertrophy. J. Cell Biol. 151, 117–130 (2000).
Morisco, C. et al. Glycogen synthase kinase 3β regulates GATA4 in cardiac myocytes. J. Biol. Chem. 276, 28586–28597 (2001).
Antos, C.L. et al. Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. USA 99, 907–912 (2002).
Cohen, P. & Frame, S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2, 769–776 (2001).
Persad, S. et al. Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J. Biol. Chem. 276, 27462–27469 (2001).
Ivaska, J. et al. Integrin α2β1 mediates isoform-specific activation of p38 and upregulation of collagen gene transcription by a mechanism involving the α2 cytoplasmic tail. J. Cell Biol. 147, 401–416 (1999).
Norton, G.R. et al. Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction. J. Am. Coll. Cardiol. 39, 664–671 (2002).
Esposito, G. et al. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 105, 85–92 (2002).
Wang, Y. Signal transduction in cardiac hypertrophy—dissecting compensatory versus pathological pathways utilizing a transgenic approach. Curr. Opin. Pharmacol. 1, 134–140 (2001).
MacLellan, W.R. Advances in the molecular mechanisms of heart failure. Curr. Opin. Cardiol. 15, 128–135 (2000).
Nicol, R.L. et al. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J. 20, 2757–2767 (2001).
Wollert, K.C. et al. The cardiac Fas (APO-1/CD95) Receptor/Fas ligand system relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes. Circulation 101, 1172–1178 (2000).
Schwartz, M.A. & Ginsberg, M.H. Networks and crosstalk: integrin signalling spreads. Nat. Cell Biol. 4, E65–E658 (2002).
Lembo, G. et al. Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. J. Clin. Invest. 98, 2648–2655 (1996).
Belkin, A.M. et al. Muscle β1D integrin reinforces the cytoskeleton-matrix link: modulation of integrin adhesive function by alternative splicing. J. Cell Biol. 139, 1583–1595 (1997).
Brancaccio, M. et al. Differential onset of expression of α7 and β1D integrins during mouse heart and skeletal muscle development. Cell Adhes. Commun. 5, 193–205 (1998).
Condorelli, G. et al. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation 99, 3071–3078 (1999).
Cabodi, S. et al. A PKC-β/Fyn-dependent pathway leading to keratinocyte growth arrest and differentiation. Mol. Cell 6, 1121–1129 (2000).
Acknowledgements
We thank O. Azzolino, I. Carfora and G. Russo for technical assistance; D. Bongioanni, B. Canepa, R. Ferretti and M. Sbroggiò for help with several experiments; V. Poli and S. Cabodi for suggestions and critical reading of the manuscript; and A. Fubini for great enthusiasm and support in the initial analysis of the mouse phenotype. This work was supported by grants from Telethon to G.T., the Ministry of University and Research to G.T. and G.L., the Italian National Research Council to F.A. and E.H., and the Italian Ministry of Health to G.L.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Brancaccio, M., Fratta, L., Notte, A. et al. Melusin, a muscle-specific integrin β1–interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nat Med 9, 68–75 (2003). https://doi.org/10.1038/nm805
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm805
This article is cited by
-
Nicotinamide riboside kinase-2 regulates metabolic adaptation in the ischemic heart
Journal of Molecular Medicine (2023)
-
The intercalated disc: a mechanosensing signalling node in cardiomyopathy
Biophysical Reviews (2020)
-
Dual inhibition of sodium–glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction
Cardiovascular Diabetology (2018)
-
Mechanisms of physiological and pathological cardiac hypertrophy
Nature Reviews Cardiology (2018)
-
Zebrafish VCAP1X2 regulates cardiac contractility and proliferation of cardiomyocytes and epicardial cells
Scientific Reports (2018)